National meeting about advanced molecular cancer diagnostics
Tuesday the 11th of June oncologist and pathologist from all the University Hospitals in Norway gathered at the Radiumhospital to discuss implementation of personalized medicine in cancer treatment.
The meeting was organized by the Division of Cancer Medicine at OUS to highlight the needs and challenges related to the advanced molecular diagnostics needed for implementation of personalized medicine in both clinic practice and clinical trials.
Published in Level 2 journals, first or last author from Oslo University Hospital.
Parvan R, Becker V, Hosseinpour M, Moradi Y, Louch WE, Cataliotti A, Devaux Y, Frisk M, Silva GJJ, AtheroNET COST Action CA21153(2025) Prognostic and predictive microRNA panels for heart failure patients with reduced or preserved ejection fraction: a meta-analysis of Kaplan-Meier-based individual patient data BMC Med, 23(1), 409 DOI 10.1186/s12916-025-04238-0, PubMed 40624658
Gjefsen E, Bråten LC, Espeland A, Goll GL, Storheim K, Zwart JA(2025) Reply: Correspondence to Efficacy of a Tumor necrosis Factor Inhibitor in Chronic Low-Back Pain with Modic type 1 Changes: A Randomized Controlled Trial Arthritis Rheumatol(in press) DOI 10.1002/art.43309, PubMed 40621716
Brustugun OT, Grønberg BH, Aanerud M, Paulsen EE, Fjellbirkeland L(2025) Lung Cancer in Norway J Thorac Oncol, 20(7), 839-846 DOI 10.1016/j.jtho.2025.03.046, PubMed 40617667